# Correction to “Treating Hematological Malignancies With OR‐2100, an Orally Bioavailable Prodrug of Decitabine”

PMC · DOI: 10.1111/cas.70230 · 2025-10-20

## Full-text entities

- **Diseases:** Hematological Malignancies (MESH:D019337)
- **Chemicals:** Decitabine (MESH:D000077209), OR-2100 (MESH:C000715549)

---
Source: https://tomesphere.com/paper/PMC12775565